Baxter International (BAX) Stock: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$23.50
-1.96 (-7.70%)
▼
5d:
-8.38%
30d:
-2.08%
90d:
-10.17%
WAIT
LOW Confidence
Analysis Updated: Oct 29, 2026 12:00 AM ET
Earnings: Oct 29, 2026
0d
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BAX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BAX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.96
Based on -11.2% avg growth
INTRINSIC VALUE TODAY
$6.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $23.50, which is considered oversold relative to its 30-day fair value range of $23.55 to $25.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.5) compared to its historical average (10.1). At these levels, the market is pricing in 4.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is currently testing key support at $23.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.7% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.92 (+18.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is currently testing key support at $23.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.7% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.92 (+18.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.55 -
$25.12
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
Protect Your Profits
Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.7%)
- BULLISH: Trading below Wall St target ($27.92)
- NEUTRAL: Market pricing in 4.3% annual earnings growth - fairly valued
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.55 -
$25.12
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$23.37
Resistance Level
$26.10
Current Trend
Strong Downtrend
Technical data as of
Oct 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.52
Wall Street Target
$27.92
(+18.8%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
36.8%
Profit Margin
-9.3%
Valuation Premium vs History
+4.3% premium
PE vs Historical
11.5 vs 10.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.3%
(market-implied from PE analysis)
1-Year Target
$24.51
(+4%)
2-Year Target
$25.56
(+9%)
3-Year Target
$26.66
(+14%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$23.37
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -26.4%)
$40.19
(+71%)
Base:
(SPY PE: 11.5, Growth: -26.4%)
$23.31
(-1%)
Bear:
(PE: 9.8, Growth: -26.4%)
$19.82
(-16%)
Share & Embed Analysis
Last updated: October 30, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$478 | 33 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 37 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$201 | 46 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$416 | 38 SELL |
|
WRBY
Warby Parker Inc |
STRONG BUY
13 analysts |
$31 | 57 HOLD |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
